Status:
COMPLETED
Capturing Parkinson's Disease Medication Side Effects During Daily Activities
Lead Sponsor:
Great Lakes NeuroTechnologies Inc.
Collaborating Sponsors:
University of Rochester
Conditions:
Parkinson's Disease
Dyskinesia
Eligibility:
All Genders
18-90 years
Brief Summary
The purpose of the study is to test whether body-worn wireless motion sensors can measure dyskinesias (involuntary movements caused by medications) in individuals with Parkinson disease (PD) independe...
Eligibility Criteria
Inclusion
- Clinical diagnosis of probable or definite idiopathic Parkinson Disease with motor fluctuations that include dyskinesias after taking their usual dose of levodopa/carbidopa
Exclusion
- Antipsychotic medications (including quetiapine and clozapine)
- Coexisting neurologic disease such as stroke or dementia
- Lacking capacity for informed consent
- Residing in a nursing home
- comorbid non-neurologic illnesses that impacts the ability to perform the study tasks
- Implantable defibrillators
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01429207
Start Date
August 1 2011
Last Update
June 29 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester Medical Center
Rochester, New York, United States, 14642